The influence of seizures on myocardial function assessed with biomarkers and echocardiography

The influence of seizures on myocardial function assessed with biomarkers and echocardiography - Seizures and myocardial function

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031329

Enrollment

Registered

2024-03-04

Start date

2024-04-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G40

Interventions

Group 1: Patients who undergo electroconvulsive therapy The following investigations will be conducted at the specified time points: 1. Blood sample upon patient admission. 2. Blood sample (blood gas

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Adult patients who are hospitalized in the Department of Psychiatry and are undergoing Electroconvulsive Therapy (ECT) treatment. The treatment is based on a psychiatric treatment indication and is independant from this study. - Signed informed consent - Clear and unambiguous comprehension of the study's disclosure

Exclusion criteria

Exclusion criteria: - Individuals who are in a dependent/employment relationship with any of the investigators. -Inability to comply with the study protocol. - Lack of a written informed consent form.

Design outcomes

Primary

Measure	Time frame
Myocardial deformity, left heart function assessed with echocardiography	—

Secondary

Measure	Time frame
Troponine, CK, lactate, BNP	—

Countries

Germany

Contacts

Public ContactGereon Schälte

Klinik für Anästhesie

gschaelte@ukaachen.de0241 80 88179

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026